Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology. 2005 Mar 08; 64(5):934; author reply 934.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Combined Chemotherapy Protocols
Brain
Brain Neoplasms
Clinical Trials, Phase I as Topic
Dacarbazine
Dose-Response Relationship, Drug
Drug Synergism
Hematologic Diseases
Humans
Kidney
Lymphoma
Maximum Tolerated Dose
Meningeal Neoplasms
Neoplasm Recurrence, Local
Treatment Outcome
authors with profiles
Eric T. Wong, M.D.